Accompanied a study order, see S2931
Email me when S 1551 moves
Committee action, floor votes, amendments and hearings. Free, no card, no password.
Already have an account? Track S 1551. By continuing you agree to the Terms and Privacy Policy.
Summary
The bill creates a dedicated trust fund to purchase naloxone and other FDA‑approved opioid antagonists and to supply them to hospitals, emergency departments, substance‑use treatment centers, and community health centers. Funding comes from transfers by the executive office of health and human services, voluntary contributions, and interest earnings, and the money can be spent without a separate appropriation as long as the fund does not run a deficit. The measure aims to ensure a universal, statewide supply of life‑saving overdose reversal medication.
AI-generated summary — may be incomplete or inaccurate. Verify against the official bill text.
Ask about S 1551
3 free questions a day, no accountHearings
- Public Health hearing on legislation related to disease prevention, screening, and treatment, and pharmacies.Joint Committee on Public Health · Jun 11, 2025
History
- Accompanied a study order, see S2931
- Bill reported favorably by committee and referred to the committee on Health Care Financing
- Hearing scheduled for 06/11/2025 from 01:00 PM-05:00 PM in A-1
- Referred to the committee on Public Health
- House concurred
Sponsors
- John F. Keenan (D) · sponsor
- James B. Eldridge
- Julian Cyr
- Ryan C. Fattman
- Vanna Howard
Similar bills in other states
Loading the map of where bills like this one were filed.
Topics
Share
Writing about this bill? Add a live status widget to your site or newsletter. It updates as the bill moves.
Track this bill
Get an email when S 1551 moves: committee action, floor votes, amendments and hearings. Free, no card.
Track S 1551 freeOr ask your AI assistant about S 1551 directly:
Add to Claude, ChatGPT or Cursor